NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Tekla Life Sciences Investors (NYSE: HQL)

 
HQL Technical Analysis
5
As on 9th Jun 2023 HQL SHARE Price closed @ 13.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.67 & Strong Sell for SHORT-TERM with Stoploss of 17.88 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

HQLSHARE Price

Open 13.73 Change Price %
High 13.75 1 Day -0.05 -0.36
Low 13.60 1 Week 0.36 2.71
Close 13.65 1 Month -0.08 -0.58
Volume 48700 1 Year -5.68 -29.38
52 Week High 19.82 | 52 Week Low 13.11
 
NYSE USA Most Active Stocks
DDR 15.44 -4.46%
NIO 7.73 -0.77%
TWTR 53.70 0.66%
CVNA 19.07 -21.30%
BACA-U 302.00 0.67%
PLTR 15.02 -1.12%
F 13.74 1.18%
CS 0.89 1.14%
RPAI 13.15 -3.17%
AUY 5.85 -0.68%
 
NYSE USA Top Gainers Stocks
CND-WT 0.05 400.00%
APRN 8.95 67.29%
WEI 0.44 51.72%
MOTV 18.70 50.20%
SPAQ 9.20 42.41%
SPAQ 9.20 42.41%
IMPX 9.39 20.69%
BARK 1.37 20.18%
BARK 1.37 20.18%
PRTY 0.06 20.00%
 
NYSE USA Top Losers Stocks
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
PSTH-WS 1.25 -93.65%
PDOT-WS 0.62 -93.65%
CLAA-WS 0.75 -92.26%
 
 
HQL
Daily Charts
HQL
Intraday Charts
Whats New @
Bazaartrend
HQL
Free Analysis
 
HQL Important Levels Intraday
RESISTANCE13.94
RESISTANCE13.85
RESISTANCE13.79
RESISTANCE13.73
SUPPORT13.57
SUPPORT13.51
SUPPORT13.45
SUPPORT13.36
 
HQL Forecast April 2024
4th UP Forecast18.72
3rd UP Forecast17.09
2nd UP Forecast16.09
1st UP Forecast15.08
1st DOWN Forecast12.22
2nd DOWN Forecast11.21
3rd DOWN Forecast10.21
4th DOWN Forecast8.58
 
HQL Weekly Forecast
4th UP Forecast15.67
3rd UP Forecast15.02
2nd UP Forecast14.62
1st UP Forecast14.22
1st DOWN Forecast13.08
2nd DOWN Forecast12.68
3rd DOWN Forecast12.28
4th DOWN Forecast11.63
 
HQL Forecast2024
4th UP Forecast26.87
3rd UP Forecast22.63
2nd UP Forecast20.01
1st UP Forecast17.39
1st DOWN Forecast9.91
2nd DOWN Forecast7.29
3rd DOWN Forecast4.67
4th DOWN Forecast0.43
 
 
HQL Other Details
Segment EQ
Market Capital 518122400.00
Sector Financial Services
Industry Asset Management
Offical website >
 
HQL Address
HQL
 
HQL Latest News
 
Your Comments and Response on Tekla Life Sciences Investors
 
HQL Business Profile
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Address: 100 Federal Street, Boston, MA, United States, 02110
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service